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Chronic recurrent multifocal osteomyelitis (CRMO) is relatively uncommon. Even though the name suggests it is the result of
infection, this is not likely the case. Instead it is more likely the result of genetic, autoimmune, or autoinﬂammatory causes.
Although CRMO has a benign course and responds well to anti-inﬂammatory medications, it can have a very aggressive clinical
and imaging presentation overlapping with infectious osteomyelitis and malignancy. Therefore, radiologists and clinicians need
to be aware of its clinical and imaging presentation to avoid morbidity associated with more aggressive treatment. We present the
case of a ten-year-old female with CRMO as a solitaryexpansile-mixed lytic and sclerotic lesion in the distal femoral diaphysis. The
diaphyseal location and mixed lytic and sclerotic appearance are less common and have an aggressive imaging appearance. We also
review the pathophysiology, imaging ﬁndings, and therapeutic approach to this uncommon but clinically important condition.
1. Case Presentation
A 10-year-old girl presented to the orthopedic service with
a two-year history of “aching-type” pain over the anterior
distal right thigh. The pain did not radiate, was worse with
rest, and was rated as approximately 5/10 in intensity. The
discomfort waxed and waned but recently had increased in
intensityandfrequency.Ibuprofenhelpedrelievesomeofthe
pain. The patient was otherwise healthy with no history of
fevers, chills, or weight loss. She had no history of previous
surgeries nor a family history of bone or joint abnormalities,
including tumors.
Examination revealed a tender area of fusiform swelling
in the distal right thigh centered just above the superior
border of the patella with no erythema or knee eﬀusion.
Her right lower extremity was neurovascularly intact with
the exception of decreased knee reﬂex compared to the left
side. There was no inguinal lymphadenopathy. Her gait was
normal.Thepatient’swhitebloodcount(WBC)wasnormal,
erythrocyte sedimentation rate (ESR) was slightly elevated at
27mm/hr (0–20mm/hr), and C-reactive protein (CRP) was
normal at 6.1mg/L (0–7.0mg/L).
Radiographs of the femur and knee (Figure 1) revealed
an expansile, moth-eaten appearing bony lesion with poorly
deﬁned margins centered in the distal diaphysis of the femur.
There was signiﬁcant “onion skin” periosteal reaction. The
lesion spared the metaphysis and did not involve the growth
plate or the epiphysis. Computed tomography (CT) of the
chest and femur, technetium bone scan of the whole body,
and MRI of the femur and thigh were all performed within
48 hours of presentation.
CT of the distal femur following IV contrast (Figure 2)
revealed similar ﬁndings to the radiographs. Of note is
the fusiform enlargement, cortical lucencies, and periosteal
reaction centered in the distal diaphysis. CT of the chest
revealed no abnormalities.
At e c h n e t i u mb o n es c a n( Figure 3) showed the lesion
to have intense activity on both blood pool and delayed
static views. The activity was isolated to the diaphysis with2 Case Reports in Radiology
(a) (b)
Figure 1: Frontal (a) and lateral (b) radiographs of the distal right femur. The lesion is shown as an expansile, fusiform mass in the distal
femur, away from the growth plate. Medullary involvement is shown as patchy, moth-eaten lucencies. Smooth laminated onion-skin like
periosteal reaction is also seen.
Figure 2: Axial 1.25mm image enhanced CT through the lesion.
The right femoral lesion is well shown on CT, including cortical
thickening, cortical lucencies (thin white arrow), and periosteal
reaction (black arrows). Note the size discrepancy between the right
and left femurs in keeping with the clinically seen asymmetry and
fusiform swelling.
no extension to the growth plate or epiphysis. This was
conﬁrmed to be a solitary lesion.
MRI (Figure 4) again showed the mass to be expansile,
centered within the distal diaphysis with periosteal reaction.
Intrinsically the mass was T1 dark relative to yellow marrow
and T2 bright especially with fat saturation. There was
enhancement throughout the ill-deﬁned mass and some
edema and enhancement was seen in the adjacent muscula-
ture.
The case was reviewed with a pediatric orthopedic tumor
surgeon who suggested that this may be CRMO based
on the two-year history and the CT ﬁndings. The patient
started on a trial of Naproxen prior to biopsy. Two weeks
following presentation, an open bone biopsy was performed
via an approach anterolateral to the iliotibial band. Both
intramedullary and cortical bone samples from the lesion
wereobtainedandsentforpathologicalanalysis.Histological
analysis revealed reparative and reactive sclerotic bone with
ﬁbrosis and scattered chronic inﬂammatory cells consistent
with chronic osteomyelitis.
The patient had immediate signiﬁcant relief of her
symptoms with Naproxen (an NSAID). She continued on
regularNaproxenforabout6monthsandwassymptom-free,
which allowed her to resume full sporting activities. At 18
months after biopsy, attempts at discontinuing her Naproxen
resulted in recurrent pain at the site.
2. Discussion
Chronic Recurrent Multifocal Osteomyelitis (CRMO) was
ﬁrst described in 1972 in four patients with “subacute and
chronic “symmetrical” osteomyelitis” by Giedion et al. [1,
2]. However, the ﬁrst report may actually date back to a
sclerosing form of osteomyelitis described by Garre in 1893
[3]. Many of the early reports came from Scandinavian
countries, but CRMO has since been reported in most
parts of the world [4]. There have been over 200 cases of
CRMO described in the literature, but the incidence remains
unknown [2, 5]. It occurs mostly in children and adolescents
of European descent [6] but has been diagnosed in other
ethnicities and in adults [5, 7–9]. Females are aﬀected more
often than males [4, 5, 7].
Despite being recognized as a clinical entity for more
than thirty years, the origin and pathophysiology of CRMO
remains unknown [4–6, 10]. Hematogenous spread of
infection seems unlikely as pathogens are rarely cultured,
with occasional positive cultures favoured to be the result
of contamination rather than true infection [5]. Several
observations including concordant monozygotic twins and
aﬀected siblings suggest that genetic factors may play aCase Reports in Radiology 3
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Figure 3: Frontal projection femoral blood pool (a) and 2-hour delayed whole-body (b) images from 99mTc MDP bone scan. Intense
activity is present at the right distal femoral lesion. There were no other active sites, conﬁrming this to be a solitary lesion.
role. CRMO is associated with several autoimmune diseases
including inﬂammatory bowel disease, Wegner’s granulo-
matosis, and psoriasis [5]. It has also been reported as
associatedwithorasa pediatric variant ofSAPHOsyndrome
(synovitis, acne, pustulosis, hyperostosis, and osteitis) [2, 5].
Girschick et al. [10] has suggested that further research
into the areas of autoinﬂammatory, autoimmunity, errors of
metabolism, and postinfectious reactive inﬂammation may
yield some answers to CRMO’s pathogenesis [10].
Clinical presentation is variable depending on the spe-
ciﬁc site of involvement. Although the disease title includes
the term multifocal, CRMO lesions may be solitary or mul-
tiple and synchronous or metachronous [2, 5]. The clinical
course is often long-lasting with episodes of exacerbation
[4]. Regional symptoms include localized pain, tenderness
and swelling over the involved bones [5, 9]. Systemic eﬀects
can include occasional low-grade fever and slight malaise
[5]. Laboratory ﬁndings are nonspeciﬁc, with many patients
having elevated ESR and CRP, but normal WBC count [2, 5].
CRMO is generally thought of as a self-limited disease with
the majority of lesions resolving without complication [5, 7].
Although limited, the duration of symptoms can be very
p r o l o n g e di nt h er a n g eo f7t o2 5y e a r s[ 5].
As in the presented case, the long bones are a common
site of involvement. Other sites including the clavicles,
spine, pelvis, and sacroiliac joints; the anterior chest;
scapula; metatarsals and metacarpals; phalanges; tarsal
bones; mandible have also been reportedly involved to a
lesser degree [2, 6, 11]. For the purpose of this report, we
shall focus on the imaging of long bone lesions.
Radiographic evaluation of CRMO lesions can be char-
acteristic but not pathognomonic [5]. Early stage CRMO
may show decalciﬁcation or osteolysis, while later stages of
the disease may present as hyperostosis and sclerosis [6]. At
any stage, periosteal reaction may also be visualized. Tubular
bone lesions are most often found at the metaphyses of
long bones but can extend to the diaphyses and occasionally
the epiphyses [2, 5]. Initial radiographs usually demonstrate
metaphyseal disease [4], which frequently manifests as
eccentric lytic lesions adjacent to the growth plate with a
sclerotic rim separating it from the underlying bone and
limited or no periosteal reaction [5]. This metaphyseal
disease later ﬁlls in and heals with sclerosis and later
normalization of the radiographic appearance. As in our
presented case, the lesions can also involve the diaphysis,
which may result from spread of an earlier metaphyseal
lesion [5]. Diaphyseal lesions are characterized by lytic
destructive areas and periosteal reaction, which heal with
sclerosis and hyperostosis [5, 9]. Recurrent active lesions will
progressively lay down further bone adding to the expansion
and sclerotic appearance [10]( Figure 1). Active diaphyseal
lesions may show small lytic areas with regions of new
bone formation [5], a ﬁnding that is better seen on the CT
(Figure 2) of our presented case.
Focal pathology in the skeletal system can be best
detected using bone scintigraphy [1] although the result
may be negative if the inﬂammatory activity is low [5, 6].
Bone scintigraphy can identify all symptomatic lesions and
frequently clinically silent lesions as well. This may help in
the diagnosis of CRMO [2].4 Case Reports in Radiology
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Figure 4: Axial (a-b) MRI through the right thigh with coronal (c-d) MRI images through both thighs. Displayed axial images are from the
level of the white lines in (c) and (d). Sequences are as follows: (a) axial T2 fat saturated (FS) (TE 93ms. TR 5670ms.), (b) axial T1FS with
gadolinium (TE 17ms. TE 730ms.), (c) coronal T1 (TE 14ms. TR 543ms.), and (d) coronal T1FS with gadolinium (TE 14ms. TR 460ms.).
The axial T2 FS image displays the edematous high signal in the medullary space, patchy high signal cortical lesions (black arrows), cortical
thickening and periosteal reaction (thick grey arrows), and subtle surrounding soft tissue edema (thin grey arrows). Coronal T1 (c) shows
the low signal within the medullary space, a characteristic feature of involvement. After gadolinium (b,d) there is intense enhancement of
the marrow, periosteum (thick grey arrows), with some enhancement also seen in the bordering musculature (thin grey arrows).
Computedtomographyhasalimitedroleinthediagnosis
of CRMO [6]. CT ﬁndings parallel those described under
radiographic assessment, with the advantage of detecting
subtle bone destruction, especially in anatomically diﬃcult
sites like the sternum, spine, and pelvis. Sclerosis and
periosteal reaction may also be seen [5]. As shown in the
presented case, small lytic areas of active disease can be
identiﬁed on the CT (Figure 2). Its major drawback is the
signiﬁcant radiation exposure, which must be considered
especiallyinchildren[6].ACTofthechestwasalsoobtained
in our patient to rule out metastatic disease as Ewing’s
sarcoma was part of the working diﬀerential diagnosis.
MRI may be useful to further characterize lesions includ-
ingbonemarrowandadjacentsofttissueinvolvementaswell
as for surveillance [5, 6, 9]. Appearance on MRI will depend
on whether lesions are in an active or reparative phase [5].
Although normal bone marrow signal is variable in children
depending on erythropoietic activity, diaphyseal marrow is
typically fatty in adolescents appearing as bright on T1 and
intermediate signal on T2-weighted images [12]. During
active inﬂammation, MR imaging shows ﬁndings typical of
marrow edema, which appears hypointense on T1-weighted
images and hyperintense on T2-weighted images (Figure 4)
[5, 6, 9, 13]. During quiescent disease, signal intensity will
decrease on both T1- and T2-weighted sequences because
of sclerosis. MRI will also show cortical thickening and
periosteal reaction [6]. One of the key aspects of MRI
imaging is the absence of abscess or sinus tract formation as
this helps to discriminate against bacterial osteomyelitis [5].
However,CRMOmayhavesurroundingtissueinﬂammation
[5], which can be seen as adjacent soft tissue increased T2
signal and enhancement, as in the presented case (Figure 4).Case Reports in Radiology 5
MRI helps determine the best location for biopsy [6]a n d
has the added beneﬁt of not exposing pediatric patients
to ionizing radiation [5, 6]. In indeterminate cases, whole-
body MR imaging may be useful for the detection of CRMO
because it is more likely to show abnormalities compared to
lab tests or other radiological investigations [13].
Positron emission tomography (PET) has been used
clinically to detect chronic osteomyelitis, but its use in
CRMO has not been described [2]. Similarly, ultrasound has
been used in imaging bacterial osteomyelitis, but its use in
the investigation of CRMO has not been documented [2].
CRMO often remains a diagnosis of exclusion between
infectious osteomyelitis and neoplasm as there is often over-
lap of clinical and imaging ﬁndings [4, 10, 14]. Neoplasms
such as osteosarcoma, Ewing’s sarcoma, neuroblastoma,
rhabdomyosarcoma, leukemia, Langerhans’ cell histiocyto-
sis, osteoid osteoma, and osteoblastoma are often part of
the diﬀerential diagnosis [6, 10]. In our presented case, the
diﬀerential diagnosis included bacterial osteomyelitis and
Ewing’s sarcoma. Bacterial osteomyelitis was determined less
likely based on the atypical location and the absence of
abscess or sinus tract formation, while biopsy ruled out
Ewing’s sarcoma.
The primary means of diagnosing CRMO relies on clin-
ical presentation, plain radiography, and bone scintigraphy
[2]. When the diagnosis is uncertain, CT and MRI are
useful to further deﬁne the disease extent [13]. If CRMO
is the most likely consideration, CT and MRI should be
used only for radiographically occult lesions identiﬁed on
bone scan or lesions that appear atypical [2]. In a 1998
publication, Handrick et al. suggested the following imaging
strategy if the diagnosis of CRMO is considered based on
clinical presentation: (1) radiographs of the symptomatic
lesions with or without ultrasound, (2) bone scintigraphy
to identify additional lesions (i.e., multifocal disease), (3)
radiographs of any additional lesions shown on bone scan,
(4) MR imaging for further assessment of lesions that are
detected on bone scan but appear normal on radiograph and
may be clinically suspect.
ThetreatmentofCRMOmayinvolvevarioustherapeutic
agents and/or operative procedures [2]. Antibiotics are
often used for empiric therapy if a bacterial etiology is
suspected. However, once the diagnosis of CRMO is made,
antibiotics should be discontinued as they are ineﬀective
[2, 7]. Nonsteroidal anti-inﬂammatory drugs (NSAIDs)
have shown variable beneﬁt in CRMO therapy and are
considered the best choice for treatment [2, 5, 10]. Although
corticosteroids have been shown to have some eﬀect on the
disease course, their side eﬀects render them a less than ideal
choice[5].Otheralternativesmayincludeinterferon-α[2,5],
interferon-γ [2, 5], bisphosphonates [5], sulfasalazine [5,
10], methotrexate [5], colchicines [2], and gammaglobulin
[10]. Widespread use of surgical intervention has not been
reported although partial or complete claviculectomy of
clavicular lesions has been documented with some success
[2, 5].
CRMO is thought of as an uncommon disease although
the exact incidence remains unknown. Even though it is a
benign and self-limited condition, which often responds to
NSAID treatment, its radiological appearance can be aggres-
sive, overlapping with bacterial osteomyelitis and neoplasm.
Awareness of this condition and correlation with provided
clinical history can help the radiologist and clinicians
oﬀer this diagnosis, potentially sparing the patient from
unnecessary invasive testing and aggressive management [5,
14].
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